5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Treatment of 42 y/o With Grade 3 Invasive Ductal Carcinoma, ER/PR -, HER2+: Breast MRI, Biopsy of Left Axillary LN’s, Neoadjuvant Therapy With TCHP
Comments 0
Login to view comments.
Click here to Login
